<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>EXELDERM- sulconazole nitrate cream </strong><br>Ranbaxy Laboratories Inc.<br></p></div>
<h1>Exelderm<span class="Sup">®</span> (sulconazole nitrate, USP)<br>Cream, 1.0%<br>For topical use only. Not for ophthalmic use.</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="inv-2fcaff97-6b8c-48b8-b148-c79728fdfa22"></a><a name="section-1"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First"><a name="inv-e19d4d67-b10a-40d1-85ef-edf72af410fb"></a>EXELDERM (sulconazole nitrate, USP) CREAM, 1.0% is a broad-spectrum antifungal agent intended for topical application. Sulconazole nitrate, USP the active ingredient in EXELDERM CREAM, is an imidazole derivative with <span class="Italics">in vitro </span>antifungal and antiyeast activity. Its chemical name is (±)-1-[2,4-Dichloro-β-[(<span class="Italics">p</span>chlorobenzyl)thio]phenethyl]imidazole mononitrate and it has the following chemical structure:</p>
<p><a name="inv-02f11484-2e43-4a31-a333-7833fceb061c"></a><a name="ID0EPCAC"></a><img alt="structure__1" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9b963f0d-b041-43be-9434-7161eab49adb&amp;name=structure__1.jpg"></p>
<p><a name="inv-e7cb0164-1e53-4603-94a7-0f862992739a"></a>Sulconazole nitrate, USP is a white to off-white crystalline powder with a molecular weight of 460.77. It is freely soluble in pyridine; slightly soluble in ethanol, acetone, and chloroform; and very slightly soluble in water. It has a melting point of about 130°C.</p>
<p><a name="inv-fdce522e-bdf3-46e9-85fb-59c590882a13"></a>EXELDERM CREAM contains sulconazole nitrate 10 mg/g in an emollient cream base consisting of propylene glycol, stearyl alcohol, isopropyl myristate, cetyl alcohol, polysorbate 60, sorbitan monostearate, glyceryl stearate (and) PEG-100 stearate, ascorbyl palmitate, and purified water, with sodium hydroxide and/or nitric acid added to adjust the pH.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="inv-0e7ccae3-b19b-49c3-ab5c-3e04a961a909"></a><a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First"><a name="inv-919dbda0-db6d-418a-952d-45edf1c2495d"></a>Sulconazole nitrate is an imidazole derivative with broad-spectrum antifungal activity that inhibits the growth <span class="Italics">in vitro </span>of the common pathogenic dermatophytes including <span class="Italics">Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum </span>and <span class="Italics">Microsporum canis</span>. It also inhibits (<span class="Italics">in vitro</span>) the organism responsible for <span class="product-label-link" type="condition" conceptid="134870" conceptname="Pityriasis versicolor">tinea versicolor</span>, <span class="Italics">Malassezia furfur</span>. Sulconazole nitrate has been shown to be active <span class="Italics">in vitro </span>against the following microorganisms, although clinical efficacy has not been established: <span class="Italics"><span class="product-label-link" type="condition" conceptid="433968" conceptname="Candidiasis">Candida</span> albicans </span>and certain gram positive bacteria.</p>
<p><a name="inv-e098e464-e94b-472f-9d34-bad23b18ecd1"></a>A modified Draize test showed no <span class="product-label-link" type="condition" conceptid="134438" conceptname="Contact dermatitis">allergic contact dermatitis</span> and a <span class="product-label-link" type="condition" conceptid="4080920" conceptname="Phytophotodermatitis">phototoxicity</span> study showed no phototoxic or photoallergic reaction to sulconazole nitrate cream. Maximization tests with sulconazole nitrate cream showed no evidence of contact sensitization or irritation.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="inv-8c9242a2-a92c-452f-b833-268445cbda18"></a><a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First"><a name="inv-003ea0e7-7432-4705-852b-5ed6650c8fbf"></a>EXELDERM (sulconazole nitrate, USP) CREAM, 1.0% is an antifungal agent indicated for the treatment of <span class="product-label-link" type="condition" conceptid="133141" conceptname="Tinea pedis">tinea pedis</span> (athlete’s foot), <span class="product-label-link" type="condition" conceptid="4160328" conceptname="Tinea cruris">tinea cruris</span>, and <span class="product-label-link" type="condition" conceptid="135473" conceptname="Dermatophytosis">tinea</span> corporis caused by <span class="Italics">Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, </span>and <span class="Italics">Microsporum canis</span>,* and for the treatment of <span class="product-label-link" type="condition" conceptid="134870" conceptname="Pityriasis versicolor">tinea versicolor</span>.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="inv-f034a2f2-bbc2-42db-964b-35765f1b3c23"></a><a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First"><a name="inv-73f20f74-1c25-44df-b1e6-65e48b5cf8ae"></a>EXELDERM (sulconazole nitrate, USP) CREAM, 1.0% is contraindicated in patients who have a history of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to any of its ingredients.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="inv-4365e324-2064-42c2-b6f9-849a86594f79"></a><a name="section-5"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="inv-bb4910e2-da45-4569-8430-499119e0af56"></a><a name="section-5.1"></a><p></p>
<h2>General</h2>
<p class="First"><a name="inv-f6e7b48b-2890-4a6b-af0c-38faf3bea7ba"></a>EXELDERM (sulconazole nitrate, USP) CREAM, 1.0% is for external use only. Avoid contact with the eyes. If irritation develops, the cream should be discontinued and appropriate therapy instituted.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="inv-df1bffa0-0002-44d6-804e-553164a59112"></a><a name="section-5.2"></a><p></p>
<h2>Information for Patients</h2>
<p class="First"><a name="inv-43037202-96a1-4ab2-bc86-3cdc8f24633f"></a>Patients should be told to use EXELDERM CREAM as directed by the physician, to use it externally only, and to avoid contact with the eyes.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="inv-33867969-5430-4677-990b-397482900aac"></a><a name="section-5.3"></a><p></p>
<h2>Carcinogenesis and Mutagenesis and Impairment of Fertility</h2>
<p class="First"><a name="inv-cf515fa5-f56b-4447-9759-88afd8b2ae39"></a>Long-term animal studies to determine carcinogenic potential have not been performed. <span class="Italics">In vitro </span>studies have shown no mutagenic activity.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="inv-ff394ede-5b3c-4caf-bd12-9f27ca6dbae2"></a><a name="section-5.4"></a><p></p>
<h2>Pregnancy (Category C)</h2>
<p class="First"><a name="inv-932bd5bf-70a3-4d09-beee-a10938cc82c9"></a>There are no adequate and well controlled studies in pregnant women. Sulconazole nitrate should be used during pregnancy only if clearly needed. Sulconazole nitrate has been shown to be embryotoxic in rats when given in doses of 125 times the adult human dose (in mg/kg). The drug was not teratogenic in rats or rabbits at oral doses of 50 mg/kg/day.</p>
<p><a name="inv-ebbb0b17-b431-476a-b34e-ce22f6328917"></a>Sulconazole nitrate given orally to rats at a dose 125 times the human dose resulted in prolonged gestation and dystocia. Several females died during the prenatal period, most likely due to labor complications.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="inv-b32b811e-7a63-4fc5-9f78-ae75dae7e20d"></a><a name="section-5.5"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First"><a name="inv-3a906ae4-1bb4-41d4-9913-1791125d7288"></a>It is not known whether sulconazole nitrate is excreted in human milk. Caution should be exercised when sulconazole nitrate is administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="inv-73fc32cf-a766-407b-9b45-3f8b42ee0baf"></a><a name="section-5.6"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First"><a name="inv-16856cdc-a2e1-411d-9585-aa39e78e9058"></a>Safety and effectiveness in children have not been established. </p>
<p><a name="inv-70aa549d-f2e2-4085-8076-17be30c8c8ad"></a>* Efficacy for this organism in the organ system was studied in fewer than ten <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span>.</p>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="inv-14207afa-59e4-42c4-a0ec-663a3681f5d9"></a><a name="section-5.7"></a><p></p>
<h2>Geriatric Use</h2>
<p class="First"><a name="inv-9b5088e1-9f49-4903-81a0-f32e7d12eceb"></a>Clinical studies of EXELDERM CREAM, 1.0%, did not include sufficient numbers of patients aged 65 years and over to determine whether they respond differently than younger patients. Other reported clinical experience has not identified differences in responses between elderly and younger patients.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="inv-c1c34c55-7260-4d90-b0e3-f8824c9f1899"></a><a name="section-6"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First"><a name="inv-0dcd30b8-eebc-4965-aa92-68c0242c85a2"></a>There were no systemic effects and only infrequent cutaneous adverse reactions in 1185 patients treated with sulconazole nitrate cream in controlled clinical trials. Approximately 3% of these patients reported <span class="product-label-link" type="condition" conceptid="4302654" conceptname="Itching">itching</span>, 3% burning or <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">stinging</span>, and 1% <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">redness</span>. These complaints did not usually interfere with treatment.</p>
</div>
<div class="Section" data-sectionCode="34092-7">
<a name="inv-bd5be544-8ff3-4dad-833c-81ba68dd4b5f"></a><a name="section-7"></a><p></p>
<h1>CLINICAL STUDIES</h1>
<p class="First"><a name="inv-0dd06846-895a-4493-a335-a5e761d6d5b4"></a>In a vehicle-controlled study for the treatment of <span class="product-label-link" type="condition" conceptid="133141" conceptname="Tinea pedis">tinea pedis</span> (moccasin type) due to <span class="Italics">T. rubrum</span>, after 4-6 weeks of treatment 69% of patients on the active drug and 19% of patients on the drug vehicle had become KOH and culture negative. In addition, 68% of patients on the active drug and 20% of patients on the drug vehicle showed a good or excellent clinical response.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="inv-50e2ed72-1147-40d0-936f-338130e828de"></a><a name="section-8"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First"><a name="inv-7a809618-37ab-4ca4-8beb-9bd1f4992768"></a>A small amount of cream should be gently massaged into the affected and surrounding skin areas once or twice daily, except in <span class="product-label-link" type="condition" conceptid="133141" conceptname="Tinea pedis">tinea pedis</span>, where administration should be twice daily.</p>
<p><a name="inv-181f9ede-6cac-4738-a93a-ee26b3be0849"></a>Early relief of symptoms is experienced by the majority of patients and clinical improvement may be seen fairly soon after treatment is begun; however, <span class="product-label-link" type="condition" conceptid="135473" conceptname="Dermatophytosis">tinea</span> corporis/cruris and <span class="product-label-link" type="condition" conceptid="134870" conceptname="Pityriasis versicolor">tinea versicolor</span> should be treated for 3 weeks and <span class="product-label-link" type="condition" conceptid="133141" conceptname="Tinea pedis">tinea pedis</span> for 4 weeks to reduce the possibility of recurrence.</p>
<p><a name="inv-c5be96c0-8823-4403-8de0-d8e8e7fbe56a"></a>If significant clinical improvement is not seen after 4 to 6 weeks of treatment, an alternate diagnosis should be considered.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="inv-4c91f65d-fbd2-440c-9ed4-2fb483d48425"></a><a name="section-9"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First"><a name="inv-6ff70739-3610-4a59-98f1-d2247d405178"></a>EXELDERM (sulconazole nitrate, USP) CREAM, 1.0% is a smooth glossy white to off-white cream having slight characteristic odor. It is supplied as follows:</p>
<p><a name="inv-1f8e2ab4-bd29-4ec7-ba80-e12785c9d0f9"></a>15 g tube - NDC 10631-101-15</p>
<p><a name="inv-5742157d-5727-4eed-9804-62db84169d19"></a>30 g tube - NDC 10631-101-30</p>
<p><a name="inv-f486ce43-7a3c-4bc0-88bf-62bd0f814aee"></a>60 g tube - NDC 10631-101-60</p>
<p><a name="inv-2c467025-f1a8-4cb5-bf33-4df9b36620b0"></a>Avoid excessive heat, above 40°C (104°F).</p>
<p><a name="inv-188cd511-3608-4ec5-ace4-0e3ab4ab29a0"></a>To report SUSPECTED ADVERSE REACTIONS, contact the FDA at 1-800-FDA-1088 <span class="Underline">www.fda.gov/medwatch</span>. </p>
<p><a name="inv-f31b7355-36ab-4f2a-bf0d-348bbc247a36"></a><span class="Bold">RANBAXY</span></p>
<p><a name="inv-63263bd7-366f-493d-b79b-7ac3b88d46ee"></a>Jacksonville, FL 32257 USA</p>
<p><a name="inv-116531d4-b183-4e16-aa0c-12db616654d3"></a>December 2012</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="inv-c703efb5-c38f-4d0b-80cd-37ae5772b093"></a><a name="section-10"></a><p></p>
<h1>PACKAGE LABEL PRINCIPAL DRUG PANEL</h1>
<div class="Figure">
<a name="ID0E2MAC"></a><img alt="15g tube" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9b963f0d-b041-43be-9434-7161eab49adb&amp;name=15gtube.jpg"><p class="MultiMediaCaption">Exelderm 15 gram tube</p>
</div>
<div class="Figure">
<a name="ID0EDNAC"></a><img alt="15g carton" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9b963f0d-b041-43be-9434-7161eab49adb&amp;name=15gcarton.jpg"><p class="MultiMediaCaption">Exelderm 15 gram carton</p>
</div>
<div class="Figure">
<a name="ID0ELNAC"></a><img alt="30 g  tube" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9b963f0d-b041-43be-9434-7161eab49adb&amp;name=30gtube.jpg"><p class="MultiMediaCaption">Exelderm 30 gram tube</p>
</div>
<div class="Figure">
<a name="ID0ETNAC"></a><img alt="30 g carton" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9b963f0d-b041-43be-9434-7161eab49adb&amp;name=30gcarton.jpg"><p class="MultiMediaCaption"> Exelderm 30 gram carton</p>
</div>
<div class="Figure">
<a name="ID0E2NAC"></a><img alt="60 g tube" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9b963f0d-b041-43be-9434-7161eab49adb&amp;name=60gtube.jpg"><p class="MultiMediaCaption">Exelderm 60 gram tube</p>
</div>
<div class="Figure">
<a name="ID0EDOAC"></a><img alt="60 g carton" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9b963f0d-b041-43be-9434-7161eab49adb&amp;name=60gcarton.jpg"><p class="MultiMediaCaption">Exelderm 60 gram carton</p>
</div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>EXELDERM 		
					</strong><br><span class="contentTableReg">sulconazole nitrate cream</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:10631-101</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>SULCONAZOLE NITRATE</strong> (SULCONAZOLE) </td>
<td class="formItem">SULCONAZOLE NITRATE</td>
<td class="formItem">10 mg  in 1 g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>PROPYLENE GLYCOL</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>STEARYL ALCOHOL</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ISOPROPYL MYRISTATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>CETYL ALCOHOL</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>POLYSORBATE 60</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SORBITAN MONOSTEARATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ASCORBYL PALMITATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>GLYCERYL MONOSTEARATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>PEG-100 STEARATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM HYDROXIDE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>NITRIC ACID</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:10631-101-15</td>
<td class="formItem">15 g in 1 TUBE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:10631-101-30</td>
<td class="formItem">30 g in 1 TUBE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">3</th>
<td class="formItem">NDC:10631-101-60</td>
<td class="formItem">60 g in 1 TUBE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA018737</td>
<td class="formItem">02/01/2010</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Ranbaxy Laboratories Inc.
							(169932519)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant - </span>Ranbaxy Laboratories Inc. (169932519)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Contract Pharmaceuticals Limited</td>
<td class="formItem"></td>
<td class="formItem">248761249</td>
<td class="formItem">manufacture(10631-101)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 7/2013<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>eb5e8745-e610-432d-9d7f-44ea0ce77a00</div>
<div>Set id: 9b963f0d-b041-43be-9434-7161eab49adb</div>
<div>Version: 4</div>
<div>Effective Time: 20130730</div>
</div>
</div> <div class="DistributorName">Ranbaxy Laboratories Inc.</div></p>
</body></html>
